Galo Maldonado

Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis

J. Eduardo Sousa, Marco A. Costa, Alexandre Abizaid et al. · Circulation · 2003 · 199 citations · Full text

Incidence and Predictors of Very Late (≥4 Years) Major Cardiac Adverse Events in the DESIRE (Drug-Eluting Stents in the Real World)-Late Registry

J. Ribamar Costa, Amanda G. M. R. Sousa, Adriana Moreira et al. · JACC: Cardiovascular Interventions · 2010 · 58 citations

Percutaneous Coronary Intervention, Cardiovascular Epidemiology, Cardiovascular Disease +12

Volumetric Analysis of In-Stent Intimal Hyperplasia in Diabetic Patients Treated With or Without Abciximab

Áurea J. Chaves, Amanda G.M.R. Sousa, Luiz Alberto Mattos et al. · Circulation · 2004 · 37 citations · Full text

Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

Arturo Quizhpe, Fausto Feres, J. Ribamar Costa et al. · American Heart Journal · 2007 · 34 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Atherosclerosis +10

Long‐Term Clinical Outcomes of the Drug‐Eluting Stents in the Real World (DESIRE) Registry

Amanda Sousa, J. Ribamar Costa, Adriana Moreira et al. · Journal of Interventional Cardiology · 2008 · 32 citations